Canopy Growth (TSE:WEED) Reaches New 52-Week Low – Should You Sell?

Canopy Growth Corp (TSE:WEED) shares reached a new 52-week low on Monday. The company traded as low as C$0.93 and last traded at C$0.94, with a volume of 230,265 shares traded. The stock had previously closed at C$0.95.

Canopy Growth Stock Performance

The company has a market cap of C$397.66 million, a PE ratio of -1.40, a PEG ratio of -0.01 and a beta of 2.41. The company has a debt-to-equity ratio of 40.27, a quick ratio of 2.32 and a current ratio of 3.04. The firm’s 50 day moving average is C$1.27 and its 200-day moving average is C$1.37.

Canopy Growth (TSE:WEED) last released its quarterly earnings data on Friday, August 7th. The company reported C($0.03) EPS for the quarter. The business had revenue of C$81.17 million during the quarter. Canopy Growth had a negative net margin of 73.95% and a negative return on equity of 29.85%. On average, research analysts anticipate that Canopy Growth Corp will post -0.69 earnings per share for the current fiscal year.

Insider Buying and Selling at Canopy Growth

In other news, Director David Angelo Lazzarato sold 22,380 shares of the company’s stock in a transaction that occurred on Monday, September 28th. The stock was sold at an average price of C$1.29, for a total value of C$28,870.20. Following the completion of the sale, the director directly owned 108,237 shares in the company, valued at C$139,625.73. This represents a 17.13% decrease in their ownership of the stock. In the last 90 days, insiders sold 43,492 shares of company stock worth $56,105. Insiders own 0.21% of the company’s stock.

Canopy Growth Company Profile

Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands.